Working at the intersection of pharma-life science & healthcare practice.
Working to enable solutions in pharma-life sciences and healthcare practice by leveraging technology to work with real-world data in mental health and chronic diseases. By creating the world's largest RWE platform, starting with neuroscience, our vision is to transform the sector with data-driven medicine that leverages analytic and digital tools to address the unmet need.
Who We Serve
Enable use of real-world evidence in drug development and commercialization by identifying patients with unmet needs, enabling data driven research and development, providing evidence for regulatory submission and allowing quicker adoption of interventions in the market.
Deliver value-based care with improved outcomes at reduced cost, through the use of analytics and decision support, including patient reported outcomes and medication adherence.
Empower patient to take control of their own care and treatment and allow quicker access to the newest interventions.
Objectively understand outcome and cost inputs of new interventions in the market, and accurately identify the patient populations most at risk.
Allow use of real-world evidence in place of RTC’s to identify opportunities for label extension, new formulation and new mechanisms of delivery. Will also enable robust pharmacovigilance through automated data acquisition and reporting of efficacy, safety and side effects.
Providing real-world evidence to run efficient clinical trials with risk based site monitoring, and comprehensive data acquisition, paving the way for pragmatic clinical trials.